Seeks Rapid, Less Expensive Diagnostics for Alzheimer’s Disease Lilly, AbbVie, Merck, the Alzheimer’s Drug Discovery Foundation, and...

With disease-modifying treatments for Alzheimer’s disease potentially on the cusp of approval, there will be pressing demand for quick,...

Toronto-based biomedical engineers Eliav Shaked and Roy Kirshon are working on a quick, non-invasive retinal diagnostic for patients...

Gentex is partnering with an artificial intelligence medical imaging company to bring to market technology for the early detection of...

RetiSpec's technology is designed to identify Alzheimer's biomarkers years before the emergence of clinical symptoms.

Howard Fillit, M.D., Founding Executive Director and Chief Science Officer of ADDF, said, "We believe that RetiSpec's retinal scanner...

"The Gentex-RetiSpec partnership reinforces our commitment to bring to market RetiSpec's novel retinal imaging technology, a widely...

An Eye Scan For Alzheimer's? Toronto Memory Program Is Looking Into It. Dr. Sharon Cohen discuss the RetiSpec technology and the study...

The CABHI-funded RetiSpec trial will determine the safety and effectiveness of the technology through human clinical testing, and help...

The University’s collaboration with RetiSpec comes following a successful pilot clinical study demonstrating the capabilities of the...

Ontario Brain Institute backed RetiSpec to accelerate growth in Ontario, Canada. RetiSpec has developed software and “plug and play”...